Skip to main content
Signal8

Lobe Sciences Ltd. (LOBEF)

Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.

Sector: Biotechnology

Industry: Biotechnology

Lobe Sciences Ltd. logo

Lobe Sciences Ltd.

OTC:LOBEFHealthcare
+10.81%$0.0355
CLOSED
Mkt Cap$10.93M
EV-
Float83.08M
O/S308.18M
VOL933 sh
$ Vol$33
RVOL0.01×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Lobe Sciences Ltd. logoOTC:LOBEFClosed$0.0355+10.81%
Short interest (FINRA)
0.1%
Oct 30 (18d)

Float 83.08M · FMP free float

109.5K
Oct 30 (18d)prev 196.3K▼ 44.3%
1.00
Oct 30 (18d)prev 1.41▼ 29.1%
Borrow (IBKR)

The cost to borrow LOBEF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
85.7%
Nov 16 (1d)prev 100.0%▼ 14.3 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

147.1K
Oct 30 (18d)prev 20.0K▲ 635.5%
Price, short interest & fails to deliver
Short interest · today's share basis20 settlements
Fails to deliver24 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 2026109.5K sh
Oct 15, 2026196.3K sh
Sep 30, 202615.0K sh
Aug 31, 202616.0K sh
Aug 14, 202638.3K sh
Latest fails to deliver
DateShares failed
Oct 30, 2026147.1K sh
Oct 28, 202620.0K sh
Oct 23, 2026265.3K sh
Oct 20, 20267.2K sh
Oct 19, 20267.3K sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202685.7%
Nov 13, 2026100.0%
Nov 12, 202681.3%
Nov 11, 202644.2%
Nov 10, 202684.0%
75-session median 74.5%mean 64.1%range 1.2–100.0%

130 calendar days requested; 76 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for LOBEF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 109,452 LOBEF shares were sold short (0.13% of a 83.08M-share float, 1.00 days to cover).